Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO.

NIH awards $3 million grant to study synbiotic medical food for bone health in older women

The NIH/National Institute on Aging has awarded a R01 $3 million grant to study the impact of a probiotic/prebiotic (synbiotic) medical food developed by Solarea

August 23, 2023

Few medical devices are designed for children. An FDA-Children’s National collaboration aims to change that.

A collaboration between a children’s hospital and the Food and Drug Administration aims to address challenges in developing medical devices for children and infants. Children’s

January 2, 2025

Lykos cuts team by 75%, vows to keep MDMA program despite FDA veto

Lykos will be culling 75% of its workforce as it continues to work on the MDMA therapy. Image credit: Getty Images / mathisworks Lykos Therapeutics

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.